Target intelligence / Profile preview

GTPase HRas messenger RNA (HRAS mRNA)

Target
HRAS mRNA
Molecular classification
Messenger RNA, Other
01

Overview

HRas mRNA is the transcript of the HRAS gene, which encodes a member of the Ras family of small GTPases (NCBI Gene ID: 3265). The resulting HRas protein acts as a critical molecular switch in signal transduction pathways, including the MAPK and PI3K/AKT pathways, which govern cell growth, differentiation, and survival (UniProt P01112). Mutations in HRAS mRNA, particularly at codons 12, 13, or 61, lead to the production of a constitutively active protein that drives oncogenesis in various tissues, such as the bladder, thyroid, and head and neck (PubMed: 15150101). Because the HRas protein has been historically difficult to target with small molecules due to its smooth surface and high affinity for GTP, the mRNA itself has become a therapeutic target. Antisense oligonucleotides (ASOs), such as ISIS 2503, are designed to bind to the HRas mRNA sequence, promoting its degradation via RNase H and thereby preventing the synthesis of the oncogenic protein (PubMed: 11033471). This strategy aims to silence the driver of malignancy at the genetic level, offering a potential treatment for Ras-driven cancers and developmental disorders like Costello syndrome.

Other names
HRAS1 mRNAHarvey rat sarcoma virus oncogene mRNAp21 mRNA transcriptTransforming protein p21 mRNA
02

Mechanism of action

Antisense inhibition of translation and RNase H-mediated mRNA degradation

03

Biological functions

Signal transductionCell proliferationCell cycleProtein synthesis
04

Disease associations

CancerCostello syndromeBladder cancerHead and neck squamous cell carcinomaThyroid cancer
05

Safety considerations

Off-target hybridization effectsLiver toxicityThrombocytopeniaInjection site reactionsSystemic inflammatory response
06

Interacting drugs

ISIS 2503
07

Biomarkers

HRAS mutation status (e.g., G12V, G13D, Q61L)HRAS mRNA expression levels

Beyond the preview

Go deeper on GTPase HRas messenger RNA (HRAS mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GTPase HRas messenger RNA (HRAS mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call